Monthly Prescribing Reference

New Tablet Formulation of Livmarli Gets FDA Approval

When selecting the appropriate formulation of Livmarli, the patient's weight and ability to swallow tablets should be considered. Livmarli tablets are supplied in 10mg, 15mg, 20mg, and 30mg dosage ...
Monthly Prescribing Reference

New Tablet Formulation of SMA Therapy Evrysdi Gets FDA Approval

Credit: Genentech. The tablet formulation can either be swallowed whole or dispersed in a teaspoon of filtered (non-chlorinated) water. Each Evrysdi tablet contains 5mg of risdiplam and is suitable ...
The American Journal of Managed Care

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Zanubrutinib's new tablet formulation is approved for all five indications, reinforcing its market leadership among BTK inhibitors. The 160 mg tablet simplifies dosing, reducing the daily intake from ...
Business Wire

Mirum’s LIVMARLI Now FDA Approved in Tablet Formulation

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of LIVMARLI ® ...
Pharmabiz

Global & Indian pharma fuel future growth of OSD with advances in tablet-capsule technology

Global & Indian pharma attribute the growth of oral solid dosage (OSD) formulations to advances in tablet-capsule technology, continuous manufacturing, potent compound growth, supporting FDA ...
Contract Pharma

Modified Release Tablets: Strategies for Optimising Drug Delivery

In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...